Physician profile
Alan Wein
NPI 1730129727
$36,745.32
in general payments reported to CMS, 2019-2025
11 companies · $4,613 in 2025
The $4,613 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $2,421 · 2021: $7,184 · 2022: $7,516 · 2023: $7,412 · 2024: $7,483 · 2025: $4,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,472 · Food and Beverage: $1,022 · Travel and Lodging: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,540.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,472.00 |
| Food and Beverage | $1,022.13 |
| Travel and Lodging | $473.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $18,510.90 | 2023-2025 | Gemtesa |
| Urovant Sciences INC | $11,700.01 | 2021-2022 | |
| Antares Pharma, INC. | $3,000.00 | 2021 | |
| Medtronic USA, INC. | $1,421.00 | 2020 | |
| Axonics, INC. | $1,387.51 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $243.68 | 2023-2024 | Interstim |
| Abbvie INC. | $182.12 | 2023-2025 | Botox |
| Boston Scientific Corporation | $131.62 | 2025 | Axonics |
| Allergan, INC. | $116.68 | 2019 | |
| Bluewind Medical | $31.46 | 2024 | |
| Laborie Medical Technologies Corp. | $20.34 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Wein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.